New Non-opioid Analgesics: Understanding Molecular Mechanisms on the Basis of Patch-clamp and Quantum-chemical Studies - Boris V. Krylov - E-Book

New Non-opioid Analgesics: Understanding Molecular Mechanisms on the Basis of Patch-clamp and Quantum-chemical Studies E-Book

Boris V. Krylov

0,0
32,64 €

-100%
Sammeln Sie Punkte in unserem Gutscheinprogramm und kaufen Sie E-Books und Hörbücher mit bis zu 100% Rabatt.
Mehr erfahren.
Beschreibung

The monograph is a summary of methods used to study pain receptors and the results obtained in some experiments designed to study the effect of non-opioid analgesics. The molecular mechanisms of nociceptive information control in primary sensory nociceptive neurons are described based on investigations of the membrane signaling cascade (opioid-like receptor → Na+,K+-ATPase → NaV1.8 channel) observed by the authors. Based on this data, the authors conclude that the modulation of NaV1.8 channels responsible for the coding of noxious signals can be carried out due to two novel targeting mechanisms. The first of these is the activation of opioid-like receptors; the second is the activation of Na+/K+-ATPase as a signal transducer. The development of a novel class of analgesics that trigger these mechanisms should lead to a successful solution to the problem of chronic pain relief.
Chapters of the monograph cover the general methods used in studying nociceptive pain (including the patch-clamp method), and the mechanism behind the binding of different ligands to these receptors such gamma-pyrones, gamma-pyridines and cardiotonic steroids.
This monograph is a valuable reference for neuroscientists, pharmacologists and allied researchers studying pain receptors for the development of safe and effective analgesics.

Sie lesen das E-Book in den Legimi-Apps auf:

Android
iOS
von Legimi
zertifizierten E-Readern

Seitenzahl: 369

Veröffentlichungsjahr: 2017

Bewertungen
0,0
0
0
0
0
0
Mehr Informationen
Mehr Informationen
Legimi prüft nicht, ob Rezensionen von Nutzern stammen, die den betreffenden Titel tatsächlich gekauft oder gelesen/gehört haben. Wir entfernen aber gefälschte Rezensionen.



Table of Contents
Welcome
Table of Content
Title Page
BENTHAM SCIENCE PUBLISHERS LTD.
End User License Agreement (for non-institutional, personal use)
Usage Rules:
Disclaimer:
Limitation of Liability:
General:
PREFACE
Introduction and Methodology
Abstract
PHYSIOLOGY OF PRIMARY SENSORY CODING
ROLE OF ION CHANNELS IN PRIMARY SENSORY CODING
Selectivity Filter
Inactivation Gating Device
Activation Gating Device
LIMITING SLOPE PROCEDURE
Mathematical Modeling of Zeff Evaluation by the Limiting Logarithmic Voltage Sensitivity Method
m-model
m3-model
m3h_s-model
m3h_f-model
PROBABLE ROLE OF EFFECTIVE CHARGE TRANSFER IN NOCICEPTIVE INFORMATION CODING
PATCH-CLAMP RESULTS OF Zeff EVALUATION BY THE LIMITING LOGARITHMIC VOLTAGE SENSITIVITY METHOD
CONCLUSION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Possible Mechanisms of Binding of Gamma-Pyrones to the Opioid-Like Receptor
Abstract
PATCH-CLAMP INVESTIGATION OF GAMMA-PYRONES
QUANTUM-CHEMICAL STUDY OF GAMMA-PYRONES
Free Acids
Acid Anions
Sodium and Calcium Salts
Complexes with Ca2+
Sodium and Calcium Salts of Ca2+ Complexes
Energy Effects of Salt Formation and Ca2+ Chelation
CONCLUSION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Possible Mechanisms of Binding of Gamma-Pyridones to the Opioid-Like Receptor
Abstract
PATCH-CLAMP INVESTIGATION OF GAMMA-PYRIDONES
QUANTUM-CHEMICAL STUDY OF GAMMA-PYRIDONES
Free Acids
Complexes with Ca2+
Acid Anions
Calcium Salts
Сalcium Salts of Ca2+ Complexes
Energy Effects of Salt Formation and Ca2+ Chelation
Structure of Molecule F (5-hydroxy-2-hydroxymethyl-gamma-pyridone)
CONCLUSION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Possible Mechanisms of Ligand-Receptor Binding of Cardiotonic Steroids
Abstract
PATCH-CLAMP INVESTIGATION OF CARDIOTONIC STEROIDS
QUANTUM-CHEMICAL STUDY OF CARDIOTONIC STEROIDS
Ouabain and Ouabagenin
Ouabain–Ca2+ Chelate Complexes
Ouabagenin–Ca2+ Chelate Complexes
Marinobufagenin
CONCLUSION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Concluding Remarks
Abstract
OPIOID-LIKE RECEPTOR-COUPLED MECHANISM OF NaV1.8 CHANNELS MODULATION
TRANSDUCER-COUPLED MECHANISM OF NaV1.8 CHANNELS MODULATION
MODULATED RECEPTOR MECHANISM OF NaV1.8 CHANNELS CONTROL
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
GLOSSARY
REFERENCES

Frontiers in Pain Science

(Volume 1)

(New Non-opioid Analgesics: Understanding Molecular

Mechanisms on the Basis of Patch-clamp and

Quantum-chemical Studies)

Authored by:

Boris V. Krylov, Ilia V. Rogachevskii, TatianaN. Shelykh & Vera B. Plakhova

I.P. Pavlov Institute of Physiology Russian Academy of Sciences,
St Petersburg, Russia

BENTHAM SCIENCE PUBLISHERS LTD.

End User License Agreement (for non-institutional, personal use)

This is an agreement between you and Bentham Science Publishers Ltd. Please read this License Agreement carefully before using the ebook/echapter/ejournal (“Work”). Your use of the Work constitutes your agreement to the terms and conditions set forth in this License Agreement. If you do not agree to these terms and conditions then you should not use the Work.

Bentham Science Publishers agrees to grant you a non-exclusive, non-transferable limited license to use the Work subject to and in accordance with the following terms and conditions. This License Agreement is for non-library, personal use only. For a library / institutional / multi user license in respect of the Work, please contact: [email protected].

Usage Rules:

All rights reserved: The Work is the subject of copyright and Bentham Science Publishers either owns the Work (and the copyright in it) or is licensed to distribute the Work. You shall not copy, reproduce, modify, remove, delete, augment, add to, publish, transmit, sell, resell, create derivative works from, or in any way exploit the Work or make the Work available for others to do any of the same, in any form or by any means, in whole or in part, in each case without the prior written permission of Bentham Science Publishers, unless stated otherwise in this License Agreement.You may download a copy of the Work on one occasion to one personal computer (including tablet, laptop, desktop, or other such devices). You may make one back-up copy of the Work to avoid losing it. The following DRM (Digital Rights Management) policy may also be applicable to the Work at Bentham Science Publishers’ election, acting in its sole discretion:25 ‘copy’ commands can be executed every 7 days in respect of the Work. The text selected for copying cannot extend to more than a single page. Each time a text ‘copy’ command is executed, irrespective of whether the text selection is made from within one page or from separate pages, it will be considered as a separate / individual ‘copy’ command.25 pages only from the Work can be printed every 7 days.

3. The unauthorised use or distribution of copyrighted or other proprietary content is illegal and could subject you to liability for substantial money damages. You will be liable for any damage resulting from your misuse of the Work or any violation of this License Agreement, including any infringement by you of copyrights or proprietary rights.

Disclaimer:

Bentham Science Publishers does not guarantee that the information in the Work is error-free, or warrant that it will meet your requirements or that access to the Work will be uninterrupted or error-free. The Work is provided "as is" without warranty of any kind, either express or implied or statutory, including, without limitation, implied warranties of merchantability and fitness for a particular purpose. The entire risk as to the results and performance of the Work is assumed by you. No responsibility is assumed by Bentham Science Publishers, its staff, editors and/or authors for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in the Work.

Limitation of Liability:

In no event will Bentham Science Publishers, its staff, editors and/or authors, be liable for any damages, including, without limitation, special, incidental and/or consequential damages and/or damages for lost data and/or profits arising out of (whether directly or indirectly) the use or inability to use the Work. The entire liability of Bentham Science Publishers shall be limited to the amount actually paid by you for the Work.

General:

Any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims) will be governed by and construed in accordance with the laws of the U.A.E. as applied in the Emirate of Dubai. Each party agrees that the courts of the Emirate of Dubai shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims).Your rights under this License Agreement will automatically terminate without notice and without the need for a court order if at any point you breach any terms of this License Agreement. In no event will any delay or failure by Bentham Science Publishers in enforcing your compliance with this License Agreement constitute a waiver of any of its rights.You acknowledge that you have read this License Agreement, and agree to be bound by its terms and conditions. To the extent that any other terms and conditions presented on any website of Bentham Science Publishers conflict with, or are inconsistent with, the terms and conditions set out in this License Agreement, you acknowledge that the terms and conditions set out in this License Agreement shall prevail.

Bentham Science Publishers Ltd. Executive Suite Y - 2 PO Box 7917, Saif Zone Sharjah, U.A.E. Email: [email protected]

PREFACE

In 1897, at a meeting of the Society of Russian Physicians, Ivan Pavlov predicted that the last stage of the life sciences would be the physiology of the living molecule. Nowadays the last stages of molecular approaches are theoretical quantum-chemical calculational techniques and experimental patch-clamp method which really can describe the behavior of living molecules. An attempt of combined application of quantum-chemical calculations and the patch-clamp method to investigation of the nociceptive system is presented in this volume. The crosstalk between drug substances and membrane receptors is conducted in the language of molecules. The behavior of single molecules upon their ligand-receptor binding should be investigated at physiologically adequate conditions during development of new analgesics. The requirement of physiological adequacy was always taken into account when the authors tried to explain the background mechanisms governing the effects of powerful analgesics. This approach makes it possible to elucidate how the chemical structure of labile attacking molecules should be finely tuned to provide effective binding to their membrane receptor. The authors hope that this review will open a new perspective to application of molecular methods in the drug design of pain relievers. The urgent need for the development of novel analgesics is dictated by the lack of safe and effective drugs in this field of medicine, especially when the pain becomes intolerable and incurable. The arsenal of practical medicine includes an array of analgesics, which have to be applied basing on the severity of pathological conditions of the organism. Step 1 of the World Health Organization analgesic ladder consists of non-opioids, administered with or without adjuvants depending on the type of pain. Step 2 comprises step 1 agents plus opioids which can relieve mild to moderate pain. Step 3 involves step 2 agents with addition of opioids for moderate to severe pain relief. It is a matter of common knowledge that administration of opioid substances results in irreversible adverse side effects in humans. The major objective of the authors is to solve this underlying problem by creating novel analgesics which could replace opioids in clinical practice, while remaining completely safe.

This book presents our main result in elucidation of the physiological role of a novel membrane signaling pathway involving the opioid-like receptor coupled to slow sodium channels (Nav1.8) via Na+,K+-ATPase as the signal transducer. This pathway is distinct from and additional to the known mechanism of the opioidergic system functioning that involves G proteins. Activation of the opioid-like receptor further triggering the signaling pathway directed towards Nav1.8 channels provides the effectiveness and safety of our novel analgesic which is potent enough to relieve severe pain otherwise relieved exclusively by Step 3 opioids.

It is nowadays almost inevitable for reviewers of scientific material in the field of nociception to make excuses for omissions. We are sincerely sorry for not having been able to discuss all the findings in physiology of nociception and in practical medicine that would have merited attention. To include all would have defeated the purpose of this volume by making it grow out of all proportions.

This book presents an informative and valuable for physiologists and clinicians overview of primary molecular mechanisms involved in functioning of the peripheral nociceptive system. This material can be used in courses given to students specializing in physiology, psychology, and medicine, as well as to physicians training in neurology, neurosurgery, and psychiatry. The principles presented in the current volume may also be of interest to molecular biologists engaged in the drug design.

Boris V. KrylovIlia V. RogachevskiiTatiana N. ShelykhVera B. Plakhova I.P. Pavlov Institute of Physiology Russian Academy of Sciences St. Petersburg, Russia

Introduction and Methodology

Boris V. Krylov,Ilia V. Rogachevskii,Tatiana N. Shelykh,Vera B. Plakhova
I.P. Pavlov Institute of Physiology Russian Academy of Sciences, St. Petersburg, Russia

Abstract

Discovery of NaV1.8 channels has opened a new perspective to study the mechanisms of nociception. A remarkable feature of these channels is their ability to be modulated by binding of various endogenous and exogenous agents to membrane receptors coupled to NaV1.8 channels. The behavior of their activation gating system was patch-clamp recorded and analyzed by the Almers’ limiting slope method. It was established that opioid-like membrane receptors could control the functioning of NaV1.8 channels. A novel role in this mechanism is played by Na+,K+-ATPase, which serves as the signal transducer instead of G proteins. Switching on the opioid-like receptors one can selectively decrease the effective charge of NaV1.8 channel activation gating device. As a result, only the high-frequency component of nociceptive membrane impulse firing is inhibited. This is the component that transfers nociceptive information to CNS.

The three units involved in the described membrane signaling cascade (opioid-like receptor → Na+,K+-ATPase → NaV1.8 channel) are potential targets for novel analgesics. Investigation of this mechanism of nociceptive signal modulation is of major importance not only for fundamental physiology but also for clinical medicine.

Keywords: Impulse firing, Limiting slope procedure, NaV1.8 channels, Na+,K+-ATPase, Nociception, Opioid-like receptor, Patch-clamp method.